PsychoactiveMap

Psychedelic and ketamine research trials in Brazil

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

24 registered studies are counted in Brazil. By compound: 2 psilocybin, 5 DMT, 8 ayahuasca, 11 ketamine and 1 ibogaine. By registry status: 9 recruiting, 1 not yet recruiting, 1 enrolling by invitation, 10 completed, 1 withdrawn and 2 status not reported. By phase: 3 early phase 1, 5 phase 1, 7 phase 2, 3 phase 3, 2 phase 4, 3 not applicable and 1 not reported. Reported start years run from 2014 (earliest) to 2027 (latest). Studies are linked to 36 institutions.

Country is taken from the research sites linked to each registry record. A study counts once per country and may appear in several countries. Compound counts may overlap. This directory covers its linked compound hubs; the research map and MCP connector also include other compounds. Ketamine studies are counted only when PsychoactiveMap classifies them as psychiatric research; anaesthesia, sedation and pain studies are left out.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

Recruiting now

10 of the 24 counted studies are listed in the registry as recruiting (9) or not yet recruiting (1), newest start first. Status is reported by study teams and can be out of date. PsychoactiveMap does not recruit, screen or refer anyone; eligibility and contact details are on each registry record.

Title as registeredRegistry IDStatusPhaseRegistry datesInstitution and city
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of StayNCT07888933Not yet recruitingPhase 2Source start: 2027-04-30 (estimated)
Source date details

Start: 2027-04-30 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2029-01-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-03-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Institute of Psychiatry, Hospital das Clínicas, University of São Paulo Medical School, São Paulo
Inhaled DMT for Major Depressive DisorderNCT07562191RecruitingPhase 2Source start: 2026-08-01 (estimated)
Source date details

Start: 2026-08-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2027-02-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-08-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-07-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Instituto de Psiquiatria - Hospital das Clínicas - IPq - HC - USP, São Paulo; Hospital de Saúde Mental Professor Frota Pinto, Fortaleza; Complexo Hospitalar Universitário Professor Edgard Santos, Federal University of Bahia (HUPES-UFBA), Salvador; Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro (IPUB-UFRJ), Rio de Janeiro; Hospital Universitário Onofre Lopes - HUOL - UFRN, Natal
Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical TrialNCT07747324RecruitingPhase 1Source start: 2026-07-01 (actual)
Source date details

Start: 2026-07-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-08-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-08-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ribeirão Preto Medical School, Ribeirão Preto
Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.NCT07732166RecruitingEarly Phase 1Source start: 2026-04-01 (actual)
Source date details

Start: 2026-04-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-08-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-28 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Centro de Pesquisas Matteo Ricci, Rio de Janeiro
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454RecruitingPhase 3Source start: 2026-01-08 (actual)
Source date details

Start: 2026-01-08 (precision: day; source type: ACTUAL; actual)

Primary completion: 2031-04-09 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2031-09-15 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-09-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Instituto Apice, Salvador; Centro Integrado Facili, São Bernardo do Campo; Universidade Federal do Rio Grande do Norte Hospital Universitario Onofre Lopes, Natal; Instituto de Pesquisa Pensi Sandra Mutarelli Setubal, São Paulo; Sociedade Literaria e Caritativa Santo Agostinho Hospital Sao Jose, Criciúma; Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo
Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian CitiesNCT07120477RecruitingPhase 4Source start: 2026-06-01 (actual)
Saved start 2026-01-01 differs from reported 2026-06-01; the saved day is not established by this observation.
Source date details

Start: 2026-06-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-09-16 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Prefeitura de Indaiatuba, Indaiatuba
Ayahuasca, Esketamine and PTSDNCT07317206RecruitingPhase 2Source start: 2025-12-20 (actual)
Source date details

Start: 2025-12-20 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Ayahuasca, Esketamine and Body Image PerceptionNCT07317219RecruitingNot applicableSource start: 2025-12-20 (actual)
Source date details

Start: 2025-12-20 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Ayahuasca, Esketamine and Premenstrual SymptomsNCT07317232RecruitingNot applicableSource start: 2025-12-20 (actual)
Source date details

Start: 2025-12-20 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression: a Phase 2a Pilot Randomized Clinical Trial (COGUNILA)NCT06898606RecruitingPhase 1Source start: 2024-09-05 (actual)
Source date details

Start: 2024-09-05 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-08-20 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-11-20 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.780Z; registry revision: 2026-03-27 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Federal University of Latin American Integration, Foz do Iguaçu

At a glance

By compound

By registry status

StatusStudiesShare
Recruiting938%
Not yet recruiting14%
Enrolling by invitation14%
Completed1042%
Withdrawn14%
Status not reported28%

By phase

PhaseStudiesShare
Early Phase 1313%
Phase 1521%
Phase 2729%
Phase 3313%
Phase 428%
Not applicable313%
Not reported14%

Registry-listed start years

Start yearStudies
2024 and later12
2020 to 20237
2015 to 20193
2010 to 20142

All counted studies

All 24 counted studies, newest start first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Title as registeredRegistry IDStatusPhaseRegistry datesInstitution and city
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of StayNCT07888933Not yet recruitingPhase 2Source start: 2027-04-30 (estimated)
Source date details

Start: 2027-04-30 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2029-01-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-03-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Institute of Psychiatry, Hospital das Clínicas, University of São Paulo Medical School, São Paulo
Acute Effects of a Single Dose of Ayahuasca on Cerebral Metabolism in Healthy Volunteers: a PET StudyNCT07893912Enrolling by invitationEarly Phase 1Source start: 2026-10-01 (actual)
Source date details

Start: 2026-10-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-12-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Universidade de São Paulo, Ribeirão Preto
Inhaled DMT for Major Depressive DisorderNCT07562191RecruitingPhase 2Source start: 2026-08-01 (estimated)
Source date details

Start: 2026-08-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2027-02-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-08-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-07-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Instituto de Psiquiatria - Hospital das Clínicas - IPq - HC - USP, São Paulo; Hospital de Saúde Mental Professor Frota Pinto, Fortaleza; Complexo Hospitalar Universitário Professor Edgard Santos, Federal University of Bahia (HUPES-UFBA), Salvador; Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro (IPUB-UFRJ), Rio de Janeiro; Hospital Universitário Onofre Lopes - HUOL - UFRN, Natal
Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical TrialNCT07747324RecruitingPhase 1Source start: 2026-07-01 (actual)
Source date details

Start: 2026-07-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-08-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-08-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ribeirão Preto Medical School, Ribeirão Preto
Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.NCT07732166RecruitingEarly Phase 1Source start: 2026-04-01 (actual)
Source date details

Start: 2026-04-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2027-08-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-28 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Centro de Pesquisas Matteo Ricci, Rio de Janeiro
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454RecruitingPhase 3Source start: 2026-01-08 (actual)
Source date details

Start: 2026-01-08 (precision: day; source type: ACTUAL; actual)

Primary completion: 2031-04-09 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2031-09-15 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-09-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Instituto Apice, Salvador; Centro Integrado Facili, São Bernardo do Campo; Universidade Federal do Rio Grande do Norte Hospital Universitario Onofre Lopes, Natal; Instituto de Pesquisa Pensi Sandra Mutarelli Setubal, São Paulo; Sociedade Literaria e Caritativa Santo Agostinho Hospital Sao Jose, Criciúma; Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo
Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian CitiesNCT07120477RecruitingPhase 4Source start: 2026-06-01 (actual)
Saved start 2026-01-01 differs from reported 2026-06-01; the saved day is not established by this observation.
Source date details

Start: 2026-06-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2026-09-16 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Prefeitura de Indaiatuba, Indaiatuba
Ayahuasca, Esketamine and PTSDNCT07317206RecruitingPhase 2Source start: 2025-12-20 (actual)
Source date details

Start: 2025-12-20 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Ayahuasca, Esketamine and Body Image PerceptionNCT07317219RecruitingNot applicableSource start: 2025-12-20 (actual)
Source date details

Start: 2025-12-20 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Ayahuasca, Esketamine and Premenstrual SymptomsNCT07317232RecruitingNot applicableSource start: 2025-12-20 (actual)
Source date details

Start: 2025-12-20 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2026-07 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-01-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression: a Phase 2a Pilot Randomized Clinical Trial (COGUNILA)NCT06898606RecruitingPhase 1Source start: 2024-09-05 (actual)
Source date details

Start: 2024-09-05 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-08-20 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2026-11-20 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:17.780Z; registry revision: 2026-03-27 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Federal University of Latin American Integration, Foz do Iguaçu
Effects of Different Doses of Ayahuasca on Personality in Healthy VolunteersNCT07893769CompletedEarly Phase 1Source start: 2024-01-01 (actual)
Source date details

Start: 2024-01-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-09-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-09-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Universidade de São Paulo, Ribeirão Preto
Safety, Tolerability and Antidepressant Effects of DMT in Patients With DepressionNCT06094907CompletedPhase 2Source start: 2023-10-09 (actual)
Source date details

Start: 2023-10-09 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-01-15 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-03-30 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2024-05-08 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital Universitário Onofre Lopes, Natal
Safety and Tolerability of DMT in Healthy AdultsNCT05901012CompletedPhase 1Source start: 2023-04-26 (actual)
Source date details

Start: 2023-04-26 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-07-17 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-07-17 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.980Z; registry revision: 2023-10-11 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital Universitário Onofre Lopes, Natal
Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose TrialNCT03380728CompletedPhase 2Source start: 2022-10-30 (actual)
Source date details

Start: 2022-10-30 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-10-30 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-10-30 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:14.296Z; registry revision: 2024-11-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ribeirão Preto Medical School, Ribeirão Preto
Ayahuasca and Esketamine for Major DepressionNCT07212946CompletedPhase 2Source start: 2022-10-30 (actual)
Source date details

Start: 2022-10-30 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-10-30 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-10-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:18.160Z; registry revision: 2025-12-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital das Clínicas da FMRP-USP, Ribeirão Preto
Clinical Study of DMT in Healthy AdultsNCT05573568CompletedPhase 1Source start: 2022-06-01 (actual)
Source date details

Start: 2022-06-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-11-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-11-14 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2023-02-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital Universitário Onofre Lopes, Natal
Naturalistic Study of Ketamine in the Treatment of DepressionNCT05249309Status not reportedNot reportedSource start: 2021-05-01 (actual)
Source date details

Start: 2021-05-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-11-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-12-15 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:16.228Z; registry revision: 2023-09-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital de Clinicas de Porto Alegre, Porto Alegre; Hospital Moinhos de Vento, Porto Alegre
A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive DisorderNCT04338321CompletedPhase 3Source start: 2020-08-21 (actual)
Source date details

Start: 2020-08-21 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-01-20 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-07-15 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:12.343Z; registry revision: 2025-04-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Ruschel Medicina e Pesquisa Clínica Ltda, Rio de Janeiro; CPN - Centro de Pesquisa em Neurociências Ltda, Belo Horizonte; BR Trials, São Paulo; C J S Carvalho & Carvalho LTDA (Viver - Centro De Desospitalizacao Humana), São Paulo; Trial Tech Tecnologia em Pesquisas com Medicamentos, Curitiba
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant DepressionNCT04234776Status not reportedPhase 4Source start: 2018-04-03 (actual)
Source date details

Start: 2018-04-03 (precision: day; source type: ACTUAL; actual)

Primary completion: 2020-06-03 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2021-04-03 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:15.107Z; registry revision: 2020-01-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Núcleo de Pesquisas em Saúde Mental, Blumenau
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideNCT03185819CompletedPhase 2Source start: 2017-10-05 (actual)
Source date details

Start: 2017-10-05 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-03-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-03-31 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:14.289Z; registry revision: 2025-04-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Hospital São Sebastião, Turvo; Hospital Universitario Professor Edgar Santos, Salvador; Trial Tech Tecnologia em Pesquisas com Medicamentos, Curitiba; CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo do Campo
54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03097133CompletedPhase 3Source start: 2017-06-15 (actual)
Source date details

Start: 2017-06-15 (precision: day; source type: ACTUAL; actual)

Primary completion: 2019-04-11 (precision: day; source type: ACTUAL; actual)

Study completion: 2019-04-11 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:14.289Z; registry revision: 2025-04-29 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Universidade Federal Do Ceara, Fortaleza; Universidade Federal De Minas Gerais - Hospital das Clínicas, Belo Horizonte; Instituto Bairral de Psiquiatria, Itapira; Hospital Universitario Professor Edgar Santos, Salvador; CEMEC - Centro Multidisciplinar de Estudos Clínicos, Santo André; Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo
Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant DepressionNCT02914769CompletedPhase 1Source start: 2014-02 (type unknown)
Saved start 2014-02-01 differs from reported 2014-02; the saved day is not established by this observation.
Source date details

Start: 2014-02 (precision: month; source type: not reported; unknown)

Primary completion: 2016-12 (precision: month; source type: ACTUAL; actual)

Study completion: 2016-12 (precision: month; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:13.916Z; registry revision: 2025-04-06 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Draulio B de Araujo, Natal
Ketamine Use in Electroconvulsive TherapyNCT02012335WithdrawnNot applicableSource start: 2014-01 (type unknown)
Saved start 2014-01-01 differs from reported 2014-01; the saved day is not established by this observation.
Source date details

Start: 2014-01 (precision: month; source type: not reported; unknown)

Primary completion: 2016-01 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2016-01 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:13.146Z; registry revision: 2015-03-19 (precision: day; source type: ESTIMATED; estimated). Source observations do not verify a different saved scalar or establish that an event occurred.

Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.

Substance hubs for these compounds

Psilocybin | DMT | Ayahuasca | Ketamine | Ibogaine

Institution hubs in this country

Institutions in this country with at least 3 counted studies. The number is that institution's own count of studies, which can include studies not shown above if the registry lists them under another country.

Condition hubs

Condition hubs that include studies counted in this country, with the number of those studies. Conditions are matched by keyword on registered titles, so one study can appear under more than one condition.

Other country hubs

United States | Canada | Switzerland | United Kingdom | Israel | France | China | Netherlands | Germany | Spain | Austria | Australia | Poland | Czech Republic | Ireland | Denmark | Sweden | Taiwan | Argentina | Belgium | Finland | Turkey | Greece | Hungary | Italy | Mexico | Bulgaria | Egypt | Norway | Pakistan | Portugal

All trial hubs | Learn | Disclaimer